NASDAQ:XENE

Xenon Pharmaceuticals Stock Insider Trading

etoro logo Buy XENE
*Your capital is at risk
$53.46
+1.16 (+2.22%)
At Close: Jun 03, 2026

Xenon Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -60.52. In total, the insiders bought 2.47M and sold 412.02K XENE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-60.52
Buy 2.47M shares
Sell 412.02K shares
75% Buy Activity
Weak Negative Correlation
Sell Signal Medium Confidence
Mar 09, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -60.52.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Mar 09, 2026
Buy
Performance Share Units
A-Award
Kenney Christopher John
Chief Medical Officer
Officer 7 500
Value: $470.7K
Mar 09, 2026
Buy
Performance Share Units
M-Exempt
Kenney Christopher John
Chief Medical Officer
Officer 7 500
Value: $470.7K
Mar 09, 2026
Buy
Performance Share Units
A-Award
Mortimer Ian
President & CEO
CEO / President 20 000
Value: $1.26M
Mar 09, 2026
Sell
Common Shares
S-Sale
Mortimer Ian
President & CEO
CEO / President 12 479
Value: $742.5K
Mar 09, 2026
Sell
Common Shares
S-Sale
Mortimer Ian
President & CEO
CEO / President 10 072
Value: $609.1K
Mar 09, 2026
Sell
Common Shares
S-Sale
Mortimer Ian
President & CEO
CEO / President 65 000
Value: $4.03M
Mar 09, 2026
Sell
Common Shares
S-Sale
Mortimer Ian
President & CEO
CEO / President 61 652
Value: $3.70M
Mar 09, 2026
Sell
Common Shares
S-Sale
Mortimer Ian
President & CEO
CEO / President 2 449
Value: $150.0K
Mar 09, 2026
Sell
Common Shares
S-Sale
Mortimer Ian
President & CEO
CEO / President 21 515
Value: $1.30M
Mar 09, 2026
Buy
Stock Option
M-Exempt
Mortimer Ian
President & CEO
CEO / President 25 000
Value: $77.5K
Mar 09, 2026
Buy
Stock Option
M-Exempt
Mortimer Ian
President & CEO
CEO / President 75 000
Value: $630.0K
Mar 09, 2026
Buy
Common Shares
M-Exempt
Difabio Andrea
Chief Legal Officer
Officer 7 500
Value: $470.7K
Mar 09, 2026
Buy
Stock Option
M-Exempt
Mortimer Ian
President & CEO
CEO / President 105 000
Value: $498.8K
Mar 09, 2026
Buy
Stock Option
M-Exempt
Mortimer Ian
President & CEO
CEO / President 65 000
Value: $613.6K
Mar 09, 2026
Buy
Performance Share Units
M-Exempt
Mortimer Ian
President & CEO
CEO / President 20 000
Value: $1.26M
Jan 09, 2026
Buy
Restricted Share Units
A-Award
Cline Darren S
Chief Commercial Officer
Officer 20 000
Value: $843.0K
Jan 09, 2026
Buy
Share Option (Right to Buy)
A-Award
Cline Darren S
Chief Commercial Officer
Officer 40 000
Value: $1.69M
Jan 09, 2026
Buy
Restricted Share Units
A-Award
Kenney Christopher John
Chief Medical Officer
Officer 20 000
Value: $843.0K
Jan 09, 2026
Buy
Share Option (Right to Buy)
A-Award
Kenney Christopher John
Chief Medical Officer
Officer 100 000
Value: $4.22M
Jan 09, 2026
Buy
Share Option (Right to Buy)
A-Award
Difabio Andrea
Chief Legal Officer
Officer 80 000
Value: $3.37M
Jan 09, 2026
Buy
Restricted Share Units
A-Award
Difabio Andrea
Chief Legal Officer
Officer 15 000
Value: $632.3K
Jan 09, 2026
Buy
Share Option (Right to Buy)
A-Award
Mortimer Ian
President & CEO
CEO / President 350 000
Value: $14.8M
Jan 09, 2026
Buy
Restricted Share Units
A-Award
Mortimer Ian
President & CEO
CEO / President 65 000
Value: $2.74M
Jan 02, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Mortimer Ian
President & CEO
CEO / President 40 000
Value: $299.6K
Jan 02, 2026
Sell
Common Shares
S-Sale
Mortimer Ian
President & CEO
CEO / President 2 062
Value: $92.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT XENON PHARMACEUTICALS INC.
Xenon Pharmaceuticals
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment o...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE